Rich Pharmaceuticals, Inc. Research and Development Expense
Rich Pharmaceuticals, Inc. reported Research and Development Expense of $332.63 thousand for the 12-month period ending 2018-03-31, per its 10-K filed 2018-07-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2018-07-17
- Rich Pharmaceuticals, Inc. research and development expense for the quarter ending 2018-03-31 was $91.48K.
- Rich Pharmaceuticals, Inc. research and development expense for the quarter ending 2017-12-31 was $92.75K.
- Rich Pharmaceuticals, Inc. research and development expense for the quarter ending 2017-09-30 was $833.00.
- Rich Pharmaceuticals, Inc. research and development expense for the quarter ending 2017-06-30 was $147.57K.
- Rich Pharmaceuticals, Inc. research and development expense for fiscal 2018 was $332.63K, a 362.44% increase from fiscal 2017.
- Rich Pharmaceuticals, Inc. research and development expense for fiscal 2017 was $71.93K, a 327.57% increase from fiscal 2016.
- Rich Pharmaceuticals, Inc. research and development expense for fiscal 2016 was $16.82K, a 89.83% decline from fiscal 2015.
- Rich Pharmaceuticals, Inc. research and development expense for fiscal 2015 was $165.37K, a 33.58% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 44 month |
|---|---|---|---|---|---|
| 2018-03-31 | $91.48K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-17 | $184.23K derived: sum of 2 quarters · filed 2018-07-17 | $185.06K derived: sum of 3 quarters · filed 2018-07-17 | $332.63K 10-K · filed 2018-07-17 | |
| 2017-12-31 | $92.75K 10-Q · filed 2018-02-20 | $93.58K derived: sum of 2 quarters · filed 2018-02-20 | $241.16K 10-Q · filed 2018-02-20 | ||
| 2017-09-30 | $833.00 10-Q · filed 2017-12-29 | $148.41K 10-Q · filed 2017-12-29 | |||
| 2017-06-30 | $147.57K 10-Q · filed 2017-12-06 | ||||
| 2017-03-31 | $71.93K 10-K · filed 2018-07-17 | ||||
| 2016-03-31 | $7.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $7.82K derived: sum of 2 quarters · filed 2017-09-05 | $9.82K derived: sum of 3 quarters · filed 2017-09-05 | $16.82K 10-K · filed 2017-09-05 | |
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | $2.00K derived: sum of 2 quarters · filed 2017-02-13 | $9.00K 10-Q · filed 2017-02-13 | ||
| 2015-09-30 | $2.00K 10-Q · filed 2016-11-21 | $9.00K 10-Q · filed 2016-11-21 | |||
| 2015-06-30 | $7.00K 10-Q · filed 2016-08-22 | ||||
| 2015-03-31 | $165.37K 10-K · filed 2016-08-22 | ||||
| 2014-03-31 | $123.80K 10-K · filed 2015-09-17 | $123.80K 10-K · filed 2014-07-15 | |||
| 2013-03-31 | $0.00 10-K · filed 2014-07-15 |